JESSICA MOZERSKY, PHD

Jessica Mozersky, PhD

JESSICA MOZERSKY, PHD
Assistant Professor of Medicine
314-747-3534
JMOZERSKY@WUSTL.EDU

JESSICA MOZERSKY, PhD, is an Assistant Professor of Medicine at Washington University’s Bioethics Research Center and a Faculty Scholar at the Institute for Public Health. Dr. Mozersky completed her PhD in Anthropology within the Institute for Human Genetics and Health at University College London, UK. She holds a Master’s degree in Bioethics from the University of Pennsylvania. Dr. Mozersky received 4 years of postdoctoral training in bioethics and the ethical, legal, and social implications (ELSI) of genetics at the University of Pennsylvania.

Dr. Mozersky conducts empirical research on the ethical and social implications of new biomedical and genomic technologies. Dr. Mozersky is currently Multi Principal Investigator or Co-Investigator for numerous NIH funded projects regarding return of results, pre-clinical Alzheimer’s Disease, genetic testing, informed consent, and qualitative data sharing. She is also an Investigator in the Outreach, Recruitment, and Engagement Core at the Knight Alzheimer Disease Research Center where she is empirically evaluating the impact of initiatives designed to increase recruitment and representation in Alzheimer Disease research.

Dr. Mozersky is director of ethics consultations for the Institute of Clinical and Translational Sciences. Dr. Mozersky is an editorial board member of Narrative Inquiry in Bioethics: A Journal of Qualitative Research, published by Johns Hopkins University Press. She also serves as an NIH reviewer for the Special Emphasis Panel on Societal and Ethical Issues in Research.

RESEARCH SUPPORT – SELECTED CURRENT PROJECTS

1R01AG065234-01 NIH/NIA Mozersky/Hartz, PI 02/01/2020 – 01/31/2025

Returning Research Results that Indicate Risk of Alzheimer Disease to Healthy Participants in Longitudinal Studies
This project will determine the cognitive and psychosocial impact of returning research results to healthy older adults that indicate 5-year risk of developing Alzheimer Disease. Understanding this will enable future Alzheimer research studies to be designed in a way that maintains scientific integrity while also respecting participant wishes to understand their risk of developing Alzheimer Disease.
Role: PI (MPI with Hartz)

3P01AG026276-14S1 NIH/NIA Morris, PI 03/30/2023 – 04/30/2024

Exploring the Impact of Financial Compensation on Recruitment and Retention to Alzheimer Disease Research
This one-year project is using a randomized design to evaluate the impact of learning about compensation at two research recruitment timepoints: outreach events where potentially interested individuals learns about Alzheimer disease research and recruitment calls with individuals interested in joining research.
Role: PI (MPI with Gabel)

REPRESENTATIVE PUBLICATIONS